Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09XUB
|
||||
Former ID |
DCL000278
|
||||
Drug Name |
Viramidine
|
||||
Synonyms |
Ribamidine; Prodrug of Ribavirin; Ribavirin amidine; Taribavirin hydrochloride; ICN 3142; AVS-000206; AVS-206;ICN-3142; Taribavirin hydrochloride (USAN); Viramidine (TN); 1-.Beta.-D-Ribofuranosyl-1,2,4-triazole-3-carboximidine hydrochloride; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboximidamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboximidamide hydrochloride; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboximidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] | Phase 3 | [530252] | ||
Company |
Valeant Pharmaceuticals International
|
||||
Structure |
Download2D MOL |
||||
Formula |
C8H13N5O4
|
||||
Canonical SMILES |
C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=N)N
|
||||
InChI |
1S/C8H13N5O4/c9-6(10)7-11-2-13(12-7)8-5(16)4(15)3(1-14)17-8/h2-5,8,14-16H,1H2,(H3,9,10)/t3-,4-,5-,8-/m1/s1
|
||||
InChIKey |
NHKZSTHOYNWEEZ-AFCXAGJDSA-N
|
||||
CAS Number |
CAS 119567-79-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Inosine-5'-monophosphate dehydrogenase | Target Info | Inhibitor | [536317] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.